Brief: Argenx Q4 Net Income USD 774.161 Million
27/02/2025 06:00
Feb 27 (Reuters) - Argenx Q4 basic EPS USD 12.79. Q4 total operating income USD 761.22 million Q4 operating expenses USD -658.179 million
Recent news on argenx SE
See all newsArgenx falls after Vyvgart trial update on myositis drug, brokers remain positive
Brief: ArgenX Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren’S Disease
Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Brief: Argenx Q1 Total Operating Income USD 1.313 Bln
Netherlands' Argenx Q1 net sales rise 63%, profit more than doubles